SCHEMBL20179271

SCHEMBL20179271

C=CCCC(Cc1ccc(C(=O)OCc2ccc(OC(=O)C(C)C)cc2)cc1)C(=O)OCCSC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 2/20 0.36
PPARG P37231 2/20 0.35
PPARA Q07869 2/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 4/20 0.33
ALDH1A1 P00352 3/20 0.33
GAA P10253 2/20 0.33
MME P08473 1/20 0.33
ANPEP P15144 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
KDM4E B2RXH2 3/20 0.32
LMNA P02545 1/20 0.32
NPC1 O15118 2/20 0.32
HPGD P15428 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20179269 0.87 ELANE (0.36) ELANEPPARGPOLBKMT2AMEN1
SCHEMBL20168293 0.86 PPARG (0.43) ELANEPPARGPPARAKMT2AMEN1
SCHEMBL21578021 0.82 ELANE (0.44) ELANEPPARGPPARAKMT2AMEN1
SCHEMBL20179174 0.75 ELANE (0.45) ELANEKMT2AMEN1MAPTALDH1A1
SCHEMBL20179253 0.74 PPARG (0.42) ELANEPPARGPPARAKMT2AMEN1
SCHEMBL20168668 0.74 PRSS1 (0.39) ELANEPPARGPOLBKMT2AMEN1
SCHEMBL20179366 0.72 PPARG (0.42) PPARGPPARAKMT2AMEN1MAPT
SCHEMBL20168734 0.72 CA12 (0.45) PPARGPPARAMAPTLMNAHPGD
SCHEMBL20179146 0.72 CA12 (0.45) PPARGPPARAMAPTLMNAHPGD
SCHEMBL20179228 0.71 FOLH1 (0.39) ELANEPPARGPPARAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018094334-A1 PRODRUGS OF HYDROXAMATE-BASED GCPII INHIBITORS THE JOHNS HOPKINS UNIVERSITY (US) 2018-05-24 WO disclosed